QR-Code

Five-Year Experience of Etanercept as Adjunct to Intravenous Immunoglobulin for Kawasaki Disease with Coronary Artery Involvement

Objective: The Etanercept as Adjunctive Treatment for Acute Kawasaki Disease trial was a phase 3, placebo-controlled, randomized trial that evaluated etanercept use for acute Kawasaki disease (KD). Trial data suggest improved coronary artery aneurysm metrics with etanercept compared to placebo. This...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Ryan Rogers, MD, Eyal Sagiv, MD, PhD, Aaron K. Olson, MD, Michael A. Portman, MD
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2025-09-01
Schriftenreihe:Journal of Pediatrics: Clinical Practice
Schlagworte:
aneurysm
etanercept
intensification
kawasaki
TNF-α
vasculitis
Online-Zugang:http://www.sciencedirect.com/science/article/pii/S2950541025000274
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge